Jennifer Reck

@KFFHealthNews @oonatempest Thank you @KFFHealthNews and @oonatempest !!

Readers made us swoon this season, writing #HealthPolicyValentines about prescription drug pricing, medical debt, and more. Our favorite poetic lines came from @JenniferLReck and inspired this cartoon by @oonatempest. Read more newsroom favorites: kffhealthnews.org/news/article/h…

Due to the Inflation Reduction Act, #Medicare will begin negotiating the cost of several high-cost drugs starting in 2023. Our new model bill directs states to apply those negotiated rates more broadly, using the savings to reduce costs for consumers.

We updated our model legislation on #PrescriptionDrug affordability boards (PDABs) to reflect lessons learned, best practices + shared experience. Learn more about our updated #PDAB model + how it can help states lower the cost of prescription drugs: bit.ly/3Ux1Usd

What does the #InflationReductionAct mean for states? Our blog breaks down the act's major health care provisions and challenges and opportunities for states, including #Medicare prescription drug price negotiations: bit.ly/3QX7gKS

We're seeking a consultant to support effective prescription drug affordability boards. Check out the RFP to learn more: bit.ly/3HmNJQk

At the end of March, Washington joined five other states in establishing a #PrescriptionDrug Affordability Board. Learn more: bit.ly/3LOB89E #PDAB